publication venue for
- Sex-based analysis of NSTEMI processes of care and outcomes by hospital: a nationwide cohort study 2024
- Frailty to predict unplanned hospitalization, stroke, bleeding, and death in atrial fibrillation 2021
- Cost-effectiveness of low-dose colchicine in patients with chronic coronary disease in The Netherlands. 11:89-96. 2025
- Remnant cholesterol and risk of premature mortality: an analysis from a nationwide prospective cohort study. 10:543-551. 2024
- Trends in ST-elevation myocardial infarction hospitalization among young adults: a binational analysis. 10:216-227. 2024
- Association between cancer, CHA2DS2VASc risk, and in-hospital ischaemic stroke in patients hospitalized for atrial fibrillation. 9:749-757. 2023
- Sex differences in the etiology and burden of heart failure across country income level: analysis of 204 countries and territories 1990–2019. 9:662-672. 2023
- Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study. 9:621-631. 2023
- Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus. 9:537-545. 2023
- Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus: Reply. 9:547-547. 2023
- The cost-effectiveness of rivaroxaban with or without aspirin in the COMPASS trial. 9:502-510. 2023
- Temporal trends in disease-specific causes of cardiovascular mortality amongst patients with cancer in the USA between 1999 and 2019. 9:54-63. 2022
- The cost implications of a polypill for primary prevention in the TIPS-3 trial. 8:899-908. 2022
- Impact of cancer diagnosis on distribution and trends of cardiovascular hospitalizations in the USA between 2004 and 2017. 8:787-797. 2022
- Urinary sodium: worth its salt?. 8:701-702. 2022
- Global representation of heart failure clinical trial leaders, collaborators, and enrolled participants: a bibliometric review 2000–20. 8:659-669. 2022
- Association of admitting physician specialty and care quality and outcomes in non-ST-segment elevation myocardial infarction (NSTEMI): insights from a national registry. 8:557-567. 2022
- Ethnic disparities in care and outcomes of non-ST-segment elevation myocardial infarction: a nationwide cohort study. 8:518-528. 2022
- Real-world management and outcomes of 7 million patients with acute coronary syndrome according to clinical research trial enrolment status: a propensity matched analysis. 8:409-419. 2022
- GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation. 8:214-227. 2022
- Substantial decline in hospital admissions for heart failure accompanied by increased community mortality during COVID-19 pandemic. 7:378-387. 2021
- The cost implication of primary prevention in the HOPE 3 trial. 5:266-271. 2019
- Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation (GARFIELD-AF). 4:27-35. 2018
- Duration of dual antiplatelet therapy and associated outcomes following percutaneous coronary intervention for acute myocardial infarction: contemporary practice insights from the Canadian Observational Antiplatelet Study. 3:qcw051-qcw051. 2017
- Evolving quality standards for large-scale registries: the GARFIELD-AF experience.. 3:114-122. 2017